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Abstract
Background The effects of surgical procedures and the need for life-long nutrient supplementation may impact on medication
regimes, requiring changes to dosage and formulation of medicines, which can be difficult for patients following surgery. Our
pre-surgical assessment pathway involves a pharmacist with specialist knowledge of bariatric surgery, to help prepare patients for
these changes.
Objective To explore the patient-reported impact of the specialist bariatric pharmacist in pre-surgical assessment.
Setting National Health Service Hospital, United Kingdom.
Methods A two phased, retrospective study design using participants recruited from pre-surgical clinic lists. The first phase
consisted of confidential, face to face semi-structured interviews. A constant comparative analytic framework informed the
construction of the second phase, which consisted of a confidential survey to test the generalizability of the findings with a
larger cohort of patients.
Results A total of 40 participants (12 interviews, 28 surveys) were recruited to the study. The majority of participants were female
(n = 33), mean age 50 years, mean pre-surgical weight 124 kg (n = 38). The most common comorbidity was type 2 diabetes.
Participants on medication had at least one comorbidity, with the majority of conditions improved or eliminated after surgery.
Conclusions The pre-surgical consultation with the pharmacist was highly valued by the participants, providing information and
support which helped prepare for medication changes after bariatric surgery. Many felt that a post-surgical appointment with the
pharmacist would provide support and improve compliance with vitamins and medications. Future research into the role of
pharmacists in the bariatric multi-disciplinary team and patient support are recommended.
Keywords Bariatric surgery . Patient experience . Pharmacist . Medication compliance . Multi-disciplinary team . Vitamins .
Supplementation
Introduction
Many people with obesity who seek bariatric surgery have
related comorbidities, necessitating polypharmacy. In the
UK, 64% of patients undergoing bariatric procedures have
three or more obesity-related health conditions [1]. The
malabsorptive and restrictive effects of bariatric surgical pro-
cedures and resultant rapid weight loss necessitate life-long
vitamin and mineral supplementation surgery [2]. This often
means altered pharmacokinetics of medications, e.g. dose,
formulation and timing [3, 4] which vary according to the
individual health status of patients. Additionally, there is a
need for lifelong follow-up and nutritional supplementation.
Bariatric surgery is time of immense physical, social and per-
sonal change [5, 6] which requires a period of adjustment for
patients.
To prepare for surgery, UK patients attend appointments
with members of the bariatric multi-disciplinary team
(MDT) to ensure that they meet individualised targets, e.g.
weight loss or changes to health behaviours, demonstrating
their ability to adapt to post-surgical lifestyle changes [7].
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Once a patient is cleared for surgery, they attend our pre-
surgical assessment clinic which has an embedded pharmacist
as part of our MDT. During pre-surgical assessment, all pa-
tients have an appointment with the pharmacist, who carries
out a medication review, integrating changes to current med-
ication post-surgery, discusses compliance with nutritional
supplementation after surgery, highlighting issues regarding
the timing, duration and interaction with specific medication
and vitamins. The pharmacist actively encourages patients to
ask questions and discuss their concerns. At the end of the
appointment, a written summary is given to the patient, with
copies sent to their General Practitioner and incorporated into
their hospital records to ensure that information is available to
all parties involved in the patients’ care.
There is an increasing drive to involve patients in clinical
research to ensure that studies are carried out which are rele-
vant to patients and provide opportunities for patients to be
included in decisions about research from design to dissemi-
nation [8]. In the UK, as part of ethical approval process for
research carried out in National Health Services (NHS) set-
tings, applications must demonstrate patient involvement in
the research as part of the approval process [9].
Our unit actively carries out patient-focused research, with
and for patients. The idea for this study was based on findings
from a previous study which explored how patients adjust to
life after bariatric surgery [5]. Findings showed that patients
reported issues around medication and supplementation com-
pliance which warranted further investigation. Many partici-
pants discussed the importance of pre-surgical contact with
the bariatric MDT in preparing for and adjusting to life after
surgery which we decided to explore further with this study.
The inclusion of a pharmacist in pre-surgical pre-assess-
ment is unique to our service and is not standard practice
within UK bariatric surgical units. In order to further engage
with patients to co-create research studies which incorporate
the views and needs of our patients, the aim of this study was
to explore the patient-reported impact of the pharmacist in pre-
bariatric surgical assessment.
Methods
A retrospective, two phased, study design with participants
randomly recruited from pre-surgical assessment clinic lists
by an independent researcher in a large National Health
Service (NHS) hospital in the UK. As all patients in our ser-
vice attend pre-surgical assessment, all patients on the pre-
surgical clinic lists were eligible to participate. The first phase
involved individual, face to face semi-structured interviews,
assisted by a topic guide, which were audio-recorded and
transcribed verbatim. Participants were asked to voluntarily
take part by discussing their experiences of seeing the phar-
macist during pre-surgical assessment. Each interview was
carried out by the same independent researcher and took be-
tween 30 and 45 min. A constant comparative approach was
used, which means that data collection and analysis were un-
dertaken concurrently, with analysis guiding further sampling
[10]. This approach allowed researchers to discover areas of
interest and to identify concepts of importance to participants
and explore these further. Data collection and analysis contin-
ued until no new concepts were identified, meaning data was
saturated and recruitment to phase 1 ceased. The findings
Table 1 Participant demographics (phase 1—interviews)
Participant
(surveys)
Gender Age Time since
surgery
(months)
Type of procedure Self-reported weight
at time of surgery (kg)
Self-reported weight loss
at time of interview (kg)
Self-reported weight at
time of interview (kg)
A F 46 8 Roux-en-Y Gastric bypass 140 44 96
B F 61 13 Roux-en-Y Bypass
(conversion from sleeve
gastrectomy)
123 12 111
C F 53 10 One Anastomosis gastric
bypass
111 38 73
D F 63 10 Roux-en-Y Gastric Bypass 138 42 96
E F 60 10 Roux-en-Y Gastric Bypass 102 31 71
F M 61 6 One Anastomosis Gastric
Bypass
154 21 133
G F 65 24 Roux-en-Y Gastric Bypass 126 57 69
H F 56 18 Roux-en-Y Gastric Bypass 120 70 70
I F 47 12 One Anastomosis Gastric
Bypass
120 51 69
J F 45 8 One Anastomosis Gastric
Bypass
118 32 86
K F 54 24 Roux-en-Y Gastric Bypass 133 57 57
L F 60 15 Roux-en-Y Gastric Bypass 111 47 64
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informed the construction of the second phase, which
consisted of a confidential survey to test the generalizability
of the findings with a larger cohort of patients. During the
interviews and data analysis for phase 1, it was noted that
participants preferred to discuss the impact of the pharmacist
appointment in terms of preparation for surgery, dealing with
changes to health status and medication after surgery.
Participants did not routinely discuss amount of weight loss,
despite collecting data on this as part of the participant demo-
graphics. In order to focus on the aim of the study and to
reduce the number of questions to encourage responses, ques-
tions around weight loss were not included in the survey. Prior
to distributing study information, the survey was pilot tested
with a representative group of patients, who confirmed that the
emphasis should be on patient experiences and not on clinical
outcomes.
For phase 2, participants were also identified from clinic
lists, with an information pack containing the study informa-
tion and a link to an on-line survey using Survey Monkey®,
with the option of requesting a printed copy, by post. To pro-
tect confidentiality, no reminders were sent. Ethical approvals
were granted by the National Health Service, Hospital and
University research ethics committees. Data were collected
between April 2017 and January 2018.
Results
A total of 40 participants (33 female, 7 male) took part in
the study, with 12 being interviewed (phase 1) and 28
filling in on-line and printed surveys (phase 2). Owing to
a continuous and varied flow of patients progressing to
Table 2 Themes constructed from interviews
Theme In vivo quotes
Taking pills signifies illness My Dad died from kidney and liver failure and some of this was down to the medication he was on. Because of this, I
did not want to take tablets the rest of my life, and I had side effects from my blood pressure tablets. I have lost
weight and I do not have symptoms anymore and I want to come off the pills, I do not want any side-effects long or
short term. With the vitamins I am on seven tablets a day and I do not want to take so many (Participant L)
I understand that I am taking vitamins for my health and to protect myself in the future. I see it as a priority but it is still
taking pills (Participant J)
Feeling empowered by the pharmacist I wasn’t as scared as I thought I would be because she [Pharmacist] talked us [self and partner]through what would
happen around the medications after surgery and I think she made me feel more confident in myself (Participant A)
The pharmacist told me that I would have to crush to tablets and it might taste bitter, and to have a drink afterwards to
take the taste away.When I was on the ward, I got my tablet from the staff, and they just handed it to me whole. I felt
good about telling them that the pharmacist told me the tablet needed to be crushed and I would need a drink with it
to take the taste away (Participant G)
Preparing to comply with post-surgical
recommendations
I had not thought through as to what medication was going to be needed afterwards, so it was good to have the update.
If I had not had the appointment, then just been presentedwith tablets when I left the hospital, I would have been less
prepared afterwards (Participant C)
Informing and involving others in their
care
With my husband with me at the appointment, he heard everything the pharmacist said and why I needed to take these
tablets. So now, he will tell me to make sure I take my tablets on a morning, and reminding me again at night,
because I used to be terrible about forgetting to take my pills (Participant A)
I had an appointment with my GP and I explained I had met with the pharmacist and I actually took the sheet of paper
with me for the GP to have a look at and I went through with her what had been explained to me and the GP asked
how I felt about things. I said that I felt a lot better and the information helped my GP to understand what I needed
(Participant B)
The GP gave me the tablets to stop the gallstones, but he did not give me enough, or the right dosage. I had to go back
and back, so when the letter came I went back with it and said to the GP ‘this is what I need to have, you are giving
me the wrong dosage’ (Participant E)
Valuing the expertise of the pharmacist If I had not seen the pharmacist, I would have probably been more scared waking up the next day after the operation
and someone coming up and saying I had to take these tablets. I thought it was quite interesting to speak with the
pharmacist about this well before the operation (Participant A)
Nobody, except the pharmacist, told me about not being able to take certainmedications anymore. She explained why I
could not take co-codamol after surgery. She said if I had amigraine, I would need to take paracetamol and that I had
to cut codeine out completely. I was worried as I was reliant on it at the time, but I appreciated the time she took to
explain everything to me (Participant K)
My pharmacist appointment was critical. You need to understand what you are taking and why you are taking it, but
also having the structure. It was really clear when I came out of the appointment what I needed to do and when. I
think if I had not met with her, I probably would not be as informed as I am (Participant L)
Wanting to help others When I was in hospital having the operation, I met a man in the next bedwho showedme an app for my phone, where I
entered all my medication, the time, the quantity etc. and it tells me when to take it and everything else. It’s called
Medisafe, and it has been so helpful. I’d recommend it to others, as it even tells you when you are running low, so
you can order a new prescription (Participant E)
After the pharmacist appointment, I bought a pill box, and it helped me to organise myself and my tablets. I would tell
everyone to do this, as there is so much to think about after surgery and you need to be prepared (Participant H)
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Table 3 Participant demographics—phase II (surveys)
Participant
(surveys)
Gender Age Time
since
surgery
(months)
Type of procedure Self-reported
weight at time
of surgery
(kg)
Self-reported
pre-surgical
health conditions
Self-reported changes
to health conditions
after surgery
1 F 46 6 One Anastomosis
Gastric Bypass
103 None reported None reported
2 M 53 6 Roux-en-Y Gastric
Bypass
142 Reflux Much improved
3 M 48 3 One Anastomosis
Gastric Bypass
248 T2D (diet and tablet
controlled),
pancreatitis, Obstructive
Sleep Apnoea, Asthma
No longer diabetic
4 F 42 2 Roux-en-Y Gastric
Bypass
121 Irritable Bowel Syndrome,
chronic pain, reflux,
depression, anxiety, arthritis
No but it is early days
5 F 43 6 Roux-en-Y Gastric
Bypass
122 Pain Reduced doses of tramadol
6 M 33 5 Roux-en-Y Gastric
Bypass
133 Obstructive Sleep Apnoea Obstructive Sleep apnoea
improved and I feel
100% better
7 M 63 5 Roux-en-Y Gastric
Bypass
107 Obstructive Sleep Apnoea,
water retention, high
blood pressure,
No Obstructive Sleep Apnoea,
no high blood pressure,
no water retention in legs,
no aches or pains
8 F 64 6 Roux-en-Y Gastric
Bypass
No response No response I am doing really well and
feel so much better
since the surgery
9 F 46 2 Roux-en-Y Gastric
Bypass
No response No response I have lost 13 kg to date
10 F 49 2 Roux-en-Y Gastric
Bypass
99 T2D,
Para hyperthyroidism
Still early days – I am only
two months out
11 F 58 N/R Roux-en-Y Gastric
Bypass
129 Hypothyroidism
Fibromyalgia
Depression
Post-surgery I suffered my
worst fibromyalgia flare up.
I was readmitted to hospital
as I was presenting with a
possible pulmonary embolism.
Nothing was found after CT
scans. Having spoken to my
fibromyalgia group I
discovered
other had similar flare ups
after surgery
12 F 50 7 One Anastomosis
Gastric Bypass
119 Back and groin pain Groin pain has eased and
I have more confidence
13 F 41 7 One Anastomosis
Gastric Bypass
119 Back, knee and
foot pain
I feel better, less pain
14 F 51 2 Sleeve Gastrectomy 91 T2D, high blood pressure Diabetes reversed almost
immediately and I expect
the blood pressure and
statin tablets to be no
longer required
15 F 46 2 One Anastomosis
Gastric Bypass
99 Rheumatoid arthritis I am in less pain as I am
carrying less weight
16 F 22 2 Roux-en-Y Gastric
Bypass
141 None, just an exceptionally
high body mass
index (BMI)
No response
17 F 62 19 Roux-en-Y Gastric
Bypass
110 Angina, spine and
neck spondylosis, irregular
heartbeat, unstable blood
pressure dropping very
low then rising very high
Angina almost gone back,
neck and knee problems
bearable without medication
18 F 31 1 Roux-en-Y Gastric
Bypass
147 T2D,Polycystic
ovarian
syndrome
No longer need metformin
and I am hoping my polycystic
ovarian syndromewill improve
19 F 52 N/R Roux-en-Y Gastric
Bypass
119 None reported
OBES SURG
surgery through the pre-surgical assessment pathway as
data was collected, an accurate response rate could not be
determined. The nature of qualitative research means that
sample sizes are smaller than quantitative studies [11] as
the aim of qualitative research is to observe, understand,
and explore a phenomena inductively, paying attention to
the meaning and actions of participants, as opposed to en-
tering a study with a pre-determined hypothesis and gener-
ating large quantities of numerical data [12]. A qualitative
approach is therefore helpful in illuminating and under-
standing individual and collective patient experiences,
which can assist in further developing support for individ-
uals who undergo bariatric surgery.
First Phase—Interviews
Twelve participants (11 female, 1 male) consented to be
interviewed (see Table 1). All participants had undergone
bypass operations, with Roux-n-Y procedures (n = 7), one
anastomosis gastric bypass (n = 4, and a revisional sleeve
gastrectomy to Roux-en-gastric bypass). Participants’
ages ranged from 45 to 63 years (mean age 56 years)
and the time since surgery ranged from 6 to 24 months
(mean time 13 months) at time of interview. The pre-
operative weight of participants ranged from 102 to
154 kg (mean pre-operative weight 124 kg) with weight
loss since surgery ranging from 12 to 70 kg (mean weight
loss 42 kg).
The interviews took place in a location of participants’
choice, including place of work, hospital, and their homes.
Each participant gave written consent; the interview was
audio-recorded and transcribed verbatim. The researcher
also took written notes during the interview, to note areas
of interest to be explored further, and to clarify any ambi-
guity to ensure that interpretation of data was veracious to
the participants’ experience and to minimise researcher bi-
as. Transcripts were compared with earlier transcripts in a
process known as constant comparative analysis, allowing
researchers to identify concepts of interest. The concepts
were discussed with the research team and a core set of
emergent themes was identified and agreed (see Table 2)
which informed the construction of the general survey
questions, for phase 2.
Table 3 (continued)
Participant
(surveys)
Gender Age Time
since
surgery
(months)
Type of procedure Self-reported
weight at time
of surgery
(kg)
Self-reported
pre-surgical
health conditions
Self-reported changes
to health conditions
after surgery
I had no illnesses but I am not
likely to get any weight
related ones now
20 F 36 3 One Anastomosis
Gastric Bypass
107 None reported None reported
21 F 67 15 Roux-en-Y Gastric
Bypass
121 Back and hip pain, mobility,
constant and
chronic pain,
bladder issues
Less pain in knees and I am
more self-confident
22 M 61 14 One Anastomosis
Gastric Bypass
140 T2D, arthritis, high
blood pressure.
n/r
23 F 61 15 Laparoscopic
banding
to Roux-en-Y
Gastric Bypass
110 Obstructive Sleep Apnoea
Hypertension Gastric
Reflux Osteoarthritis
Chronic Pain Breast Cancer
No longer need high blood
pressure medication, I have
been told I can stop my
CPAP machine. I hope to be
able to reduce my pain
medication and
eventually
24 F 72 7 Roux-en-Y Gastric
Bypass
110 T2D Diabetes much improved
25 F 27 6 Sleeve Gastrectomy 144 None reported None reported
26 F 30 7 Roux-en-Y Gastric
Bypass
136 Plantar fasciitis,
asthma,
depression
and anxiety
Plantar fasciitis has healed
completely, asthma greatly
improved and I have less
anxiety and depression
27 M 61 5 Roux-en-Y Gastric
Bypass
155 T2D I am no longer Type 2 diabetic
28 F 31 7 One Anastomosis
Gastric Bypass
155 High blood pressure,
T2D, Fibromyalgia
I am no longer hypertensive
and my diabetes is nearly gone
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Table 4 Pharmacist appointment
Participant
(surveys)
Were you aware
you would see a
pharmacist as part
of pre-surgical
assessment?
Length of
appointment
(minutes)
How did
you
attend?
Most valuable points
made by pharmacist
If you were on medication,
did the pharmacist clearly
explain reasons for the
changes to medication after
surgery?
Did pharmacist
clearly the
importance of
taking vitamins
and supplements
1 Cannot remember 15 Alone What medications I would need to
take for life after surgery
I was not on any medication
so this question does not
apply to me
Yes
2 Yes 15 With
partner
What I should be eating and what I
should avoid
Yes Yes
3 Cannot Remember Unsure With
partner
What medication will stop or start and
why. Also gave me information on
two types of procedures and the
effects of these on medications, as I
was not sure which operation I
would have until the time
Yes Yes
4 Cannot Remember 20 With
partner
New ways of taking my medications
after surgery
Yes Yes
5 Yes 10 Alone hHelp with weight loss after surgery Yes Yes
6 Yes 30 With
partner
Awareness of what medication I
would need after surgery
I was not on any medication
so this question does not
apply to me
Yes
7 Cannot Remember 10 Alone No response Yes Yes
8 Yes 30 Alone The importance of taking medication
after surgery
Yes Yes
9 Yes 10 Alone Everything Yes Yes
10 Cannot Remember 15 Alone Stopping metformin/postoperative
medication
Yes Yes
11 Yes 15 Alone To stop taking Naproxen or use
Ibuprofen gel so as to not aggravate
my stomach. Finding out what
other medications I would need.
Yes Yes
12 Yes 30 Alone No response Yes Yes
13 No 30 With
some-
one
else
Better understanding of my
medication
Yes Yes
14 No 20 With
partner
Explanation of what the new
medicines I had to take were for
Yes Yes
15 Yes 10 alone Explaining what would change after
surgery
Yes Yes
16 Yes 10 With
some-
one
else
That I have to take certain
medications for life and some for
just 6 months
I was not on any medication
so this question does not
apply to me
Yes
17 Yes 15 Alone Need for vitamins the lady also had a
bottle with salt in and explained
how much salt was in soluble pain
killers also told me not take certain
pills at same time, i.e. calcium and
iron
Yes Yes
18 Yes 20 With
partner
I was given a list of what I would be
taken and for how long all my
questions were answered and she
noted all information so I left
feeling confident
Yes Yes
19 Yes 30 Alone How important meds and aftercare are Yes Yes
20 Yes 20–30 Alone the reasons why some medications
cannot be taken and why it was
important to take others
I was not on any medication
so this question does not
apply to me
Yes
21 Yes 30 Yes Yes
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Second Phase
A total of 28 (22 females, 6 males) completed the survey
(on-line or print) (see Table 3). The types of procedures
performed were Roux-n-Y Gastric bypass 64% (n = 18),
mean pre-surgical weight was 128 kg. The most common-
ly reported health conditions were type 2 diabetes (n = 8),
pain (n = 6), and hypertension (n = 6). Improvements to
health conditions were reported by 71% (n = 20) of par-
ticipants, with 7% (n = 2) reporting it was too early to
notice a change, 3% (n = 1) had a chronic disease flare-
up post-surgery and 18% (n = 5) did not respond (see
Table 3).
Most participants were aware they were going to see a
pharmacist as part of pre-surgical assessment. Patients
attended the appointment alone or with someone else and
spent between 10 and 30 min with the pharmacist. The
participant-reported experiences of the pharmacist appoint-
ment are shown in Table 4.
The pre- and post-surgical changes to medications are
outlined in Table 5, with the majority showing a reduction in
medications. Although phase 1 identified a dichotomy between
prescription medications and nutrient supplementation in the
context of taking pills daily, the majority of respondents in
phase 2 did not perceive vitamins and minerals as ‘medication’.
The final phase of the survey asked participants to reflect
on the role of the pharmacist (see Table 6). Over three quarters
felt that the pharmacist input was valuable or extremely valu-
able, with high levels of confidence in taking medication post-
surgically. Over half (n = 16) stated the service could be im-
proved with additional appointments with the pharmacist after
surgery.
Participants were asked how the pharmacist service could
be developed further with in vivo quotes suggested as
recommendations:
‘I recommend that all patients are told to buy a pill
organiser before surgery’
Table 4 (continued)
Participant
(surveys)
Were you aware
you would see a
pharmacist as part
of pre-surgical
assessment?
Length of
appointment
(minutes)
How did
you
attend?
Most valuable points
made by pharmacist
If you were on medication,
did the pharmacist clearly
explain reasons for the
changes to medication after
surgery?
Did pharmacist
clearly the
importance of
taking vitamins
and supplements
With
partner
Some medication would change from
tablets to liquid form
22 Yes 30 With
partner
Yes Yes
23 Yes 30 Alone The pharmacist gave me the
important information I needed to
know about post-surgery so I was
aware of what to expect and how
important it was to maintain the
regime. She was also kind enough
to answer the questions I had and
arranged my medications for
discharge which was very helpful.
Yes Yes
24 Yes 10–15 Alone importance of not missing medication Yes Yes
25 No 10 Alone None it was very un-informative No No
26 No 10 Alone The importance of taking
lansoprazole to protect my new
stomach, that I would only take
ursodeoxycholic acid along with
lansoprazole for 6 months which
was a relief to hear, and that the
only medication I would take for
life would be a multivitamin and
mineral supplement.
Yes Yes
27 Yes 20 With
partner
Helped me understand what I needed
to take and at what time of the day
Yes Yes
28 Yes 20 With
some-
one
else
How I was going to take medication,
i.e. soluble and why I was taking
them
Yes Yes
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Table 5 Pre- and post-operative medications and medical equipment
Participant Type of
procedure
Self-reported
pre-surgical
medications
Self-reported
post-surgical
medications
Self-reported
difference in
medications/
equipment post-
operatively
Self-reported
vitamin and
mineral
supplementation
Did participant feel
that vitamins and
minerals were
medications?
1 One
Anastomosis
Gastric
Bypass
None None n/a No response No
2 Roux-en-Y
Gastric
Bypass
Lansoprazole Lansoprazole No medication
changes
Added:
Vitamins
B12 Yes
3 One
Anastomosis
Gastric
Bypass
Metformin,
Ventolin®
Buscopan®
Buscopan®
Lansoprazole,
Ursodeoxycholic acid
No metformin
Added:
Lansoprazole
Ursodeoxycholic
acid
Iron,
Vitamin D
B12
Yes
4 Roux-en-Y
Gastric
Bypass
Amlodipine
Oramorph® Paracetamol
Sertraline
Tapentadol Lansoprazole
Methotrexate
Folic acid
Same as before surgery No change No response No
5 Roux-en-Y
Gastric
Bypass
Tramadol Tramadol No change No response No
6 Roux-en-Y
Gastric
Bypass
None Lansoprazole
Ursodeoxycholic acid
Added:
Lansoprazole,
Ursodeoxycholic
acid
Accrete® D3
Ferrous
Fumarate
Multivitamins
Yes
7 Roux-en-Y
Gastric
Bypass
Amlodipine Doxazosin
Omeprazole Allopurinol
None All medication
stopped
No response No
8 Roux-en-Y
Gastric
Bypass
None Lansoprazole
Ursodeoxycholic acid
Added:
Lansoprazole
Ursodeoxycholic
acid
B12 injection
Ferrous
Fumarate
Multivitamin
Calcium
Carbonate
Yes
9 Roux-en-Y
Gastric
Bypass
None Lansoprazole Added:
Lansoprazole
Multivitamin,
Ferrous
Fumarate
Adcal® D3
Yes
10 Roux-en-Y
Gastric
Bypass
Metformin
Vit D
Statin
Metformin
Vitamin D,
− 1 (statin) Multivitamin Yes
11 Roux-en-Y
Gastric
Bypass
Omeprazole Naproxen
Amitriptyline
Levothyroxine
Sertraline, Atorvastatin
Pregabalin
Paracetamol, Tramadol
Fultium® D3
Omeprazole
Amitriptyline
Levothyroxine
Sertraline Atorvastatin
Pregabalin Paracetamol
Tramadol
Adcal® D3
− 1 (Naproxen) Vitamin B12
injection
Yes
12 One
Anastomosis
Gastric
Bypass
Gabapentin Amitriptyline
Nefopam
Sertraline
Same as before No change No response No response
13 One
Anastomosis
Gastric
Bypass
None Multivitamin n/a Multivitamin Yes
14 Lisinopril − 3 Yes
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Table 5 (continued)
Participant Type of
procedure
Self-reported
pre-surgical
medications
Self-reported
post-surgical
medications
Self-reported
difference in
medications/
equipment post-
operatively
Self-reported
vitamin and
mineral
supplementation
Did participant feel
that vitamins and
minerals were
medications?
Sleeve
Gastrectomy
Vitamin D Amlodipine
Atorvastatin Liraglutide
Metformin
Colecalciferol Lisinopril,
Amlodipine
Atorvastatin
Added:
Lansoprazole
(6 months only)
Ursofalk®
(6 months)
Ferrous
fumarate
Multivitamins
15 One
Anastomosis
Gastric
Bypass
Sulfasalazine,
Hydroxychloroquine
Tramadol Methotrexate
Folic Acid, Amitriptyline,
Rituximab infusion (6
monthly)
Methotrexate,
Hydroxychloroquine,
Amitriptyline
Tramadol (but not as many)
− 3 and reduced
Tramadol
Multivitamin
with minerals
Yes
16 Roux-en-Y
Gastric
Bypass
None ‘Just the ones that are
necessary for post op
patients’
None
Added:
(Asssumed to be
Lansaprazole and
Ursodeoxycholic
acid)
No response No
17 Roux-en-Y
Gastric
Bypass
Atorvastatin
Digoxin
Codeine Phosphate
Tramadol
Paracetamol
Lansoprazole Bisoprolol
(2.5 mg am and
1.5 mg pm)
Atorvastatin
− 4
Added:
Lansaprazole
Adcal®
Ferrous
Fumarate
Calcium
Vitamin B12
injection
every
12 weeks
Yes
18 Roux-en-Y
Gastric
Bypass
Metformin ‘Only ones prescribed from
operation’
No metformin
Added:
(Asssumed to be
Lansaprazole and
Ursodeoxycholic
acid)
No response No
19 Roux-en-Y
Gastric
Bypass
None Acarbose + 1 Vitamins Yes
20 One
Anastomosis
Gastric
Bypass
None Lansoprazole (6 months) Added:
Lansoprazole
(6 months)
Multivitamin,
Iron,
Calcium,
Yes
21 Roux-en-Y
Gastric
Bypass
Amitriptyline
Bendroflumethiazide
Felodipine Paracetamol
Loratadine
Carbomer
Estriol
Uriplan® Carbamazepine
Pregabalin
Zomorph® Lansoprazole
Medications have stayed
the same, but doses have
been reduced with some
(not stated)
No
22 One
Anastomosis
Gastric
Bypass
Simvastatin, Doxazosin,
Paracetamol
Losartan
Losec®
None − 5 Ferrous
fumarate
Accrete
Yes
23 Laparoscopic
banding to
Roux-en-Y
Gastric
Bypass
Omeprazole Tramadol
Paracetamol Fluoxetine
Metoprolol
Omeprazole
Loperamide
Paracetamol Tramadol
− 1 Multivitamin
Vitamin B12,
Adcal®
Iron supplement
Yes
24 Diabetes medication × 3
(not stated)
Amitriptyline, Cetirizine
Spironolactone
− 4 Ferrous
fumarate
Yes
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‘Having a pharmacist available for patients who are
discharged on a weekend’
‘Amore detailed leaflet which describes all the vitamins
and what to take and when’
‘It was all explained very well to me, but listening to the
other patients on the ward after surgery I feel that some
people just don’t listen carefully to the pharmacist, who
explained everything to me without being patronising’
‘It would be great to have an on-line Question and Answer
session so that if your General Practitioner leaves you
hanging, as mine did, you can get answers to your ques-
tions without needing a hospital appointment’
‘More information on being aware of how hard it is to
take tablets after surgery’
‘I firmly believe that the pharmacists’ involvement in
bariatric surgery is crucial. Patients such as myself need
a lot of support pre- and post-operatively, and the infor-
mation regarding medication and how/when to take
them and why they are being taken is important to keep-
ing us patients healthy and consistent in our progress’
Discussion
Many participants felt they had become experts in their medi-
cines management and acted as an intermediary between the
bariatric unit and the primary care team responsible for
their long-term care and follow-up, reporting that general practi-
tioners were often not aware of the need to both alter medication
regimes, or the necessity of lifelong vitamin supplementation.
The act of taking pills was important for participants. For
those on multiple medications for comorbidities, a reduction in
the number of pills taken each day signified a positive improve-
ment in their post-surgical lives. However, the need for addi-
tional pills in the form of vitamins and temporary (6 month)
medications added a layer of complexity to the adjustment after
surgery in terms of expectations. Participants felt that although
medications were ‘bad’ and vitamins were ‘good’ in terms of
complying with post-surgical advice and being healthy, the act
of taking pills itself was difficult. Additionally, there were re-
ported side effects of vitamins and supplements (e.g. constipa-
tion with ferrous fumarate), and timing of vitamins to avoid
interactions with medications was difficult to deal with and
affected compliance. For some participants, it was difficult to
separate pills in terms of medication and vitamins, for others,
the dichotomy between good (vitamins) and bad (medications),
despite the number of tablets taken increased after surgery, was
not as much of an issue and was accepted as part of the post-
surgical lifestyle. It was noted in Table 5 that there were incon-
sistencies in the patient-reported medicines after surgery, in that
some patients did not mention the post-operative medications,
or did not mention vitamins.
The discussion with the pharmacist was also thought to be
an important step in self-care and empowerment following sur-
gery. Patients reported downloading medication reminder apps
Table 5 (continued)
Participant Type of
procedure
Self-reported
pre-surgical
medications
Self-reported
post-surgical
medications
Self-reported
difference in
medications/
equipment post-
operatively
Self-reported
vitamin and
mineral
supplementation
Did participant feel
that vitamins and
minerals were
medications?
Roux-en-Y
Gastric
Bypass
Amitriptyline
Cetirizine Pantoprazole
Statin
Calcium
Vitamin D
25 Sleeve
Gastrectomy
Omeprazole Omeprazole 0 Vitiman D
Iron tablet
Vitamin B12
injection
Yes
26 Roux-en-Y
Gastric
Bypass
Citalopram, Ventolin®
inhaler
Citalopram
Ursodeoxycholic acid
Lansoprazole
− 1
Added:
Ursodeoxycholic
acid
Lansoprazole
Multivitamin
and mineral
supplement,
Yes
27 Roux-en-Y
Gastric
Bypass
Metformin No response No response No response No response
28 One
Anastomosis
Gastric
Bypass
Metformin Pregabalin
Lisinopril
Pregabalin
Metformin
Lansoprazole
Same
Added:
Lansaprazole
Calcium, Iron,
Multivitamin
and B12
injection
Yes
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on their mobile phones, carrying their medication list with
them, and having pills in certain locations (home, work, hand-
bags) to be accessible during the day and improve compliance.
Participants also reported using the information gained from
the pharmacist to initiate discussions with others involved in
their care, notably their general practitioners. Some participants
Table 6 Post-surgical reflections on the role of the pharmacist (phase 2)
Participant If you were on any
medication, how did you
feel about taking your
medication when after
surgery?
Overall, how did you use the
information you learned from the
pharmacist after surgery
Should there be a
follow-up
appointment with
the pharmacist after
surgery?
If you said yes, when
would be the best
time(s) up to
24 months after
surgery?
How valuable was
the pharmacist
involvement in your
pre-surgical
assessment?
1 Confident No response Yes 6 months Extremely valuable
2 Very confident Amended my diet Yes 6/12/24 months Valuable
3 Confident Helped to understand what to expect and
what to do
No Not needed Extremely valuable
4 Confident Helped me to understand what effect the
medications would have on me
Yes 3 months Valuable
5 Confident No response Yes 6 months Valuable
6 Very confident Implemented advice into my routine,
bought a pill organiser which has really
helped me to keep on top of what
medication I need to take
Yes 6 months Extremely valuable
7 Very confident No response No Not needed Fairly valuable
8 Very confident Helped me to take my medication Do not know 12/24 months Extremely valuable
9 Very confident Overall the information was helpful Do not know 3/6 months Extremely valuable
10 Unsure I was more aware of what was needed after
surgery
No Not needed Extremely valuable
11 Confident I made sure my General Practitioner
altered my medication
Do not know Not needed Extremely valuable
12 Very confident No response Yes 6 months Valuable
13 Very confident Helped me to understand about the
vitamins
N 6/18/24 months Valuable
14 Very confident I was more aware of what I needed the
medication and vitamins for
N 12 months Extremely valuable
15 Very confident I was more prepared for what would
happen after surgery
N Not needed Valuable
16 Very confident I took it all in but found it all a little
confusing
Y Not needed Fairly valuable
17 Fairly confident I do as I am told, but I am still having
severe constipation, if I miss the iron
tablets it is easier
N Not needed Extremely valuable
18 Very confident Helped me to organise my tablets so I have
certain ones accessible at home for the
morning, some at work and some in my
bag so I am always covered
Y 6/18/24 months Extremely valuable
19 No response Put advice into practice N Not needed Fairly valuable
20 Very confident To accurately take my medication N 6 months Extremely valuable
21 Very confident I have the list of medications to hand when
I take my tablets
y 3/6/12/18 months Extremely valuable
22 Very confident No response Y 3/12 months Extremely valuable
23 Confident I followed the advice on the sheet and
made sure I took the medications as
prescribed
Y 3/6/9/12/18 months Extremely valuable
24 Fairly confident I knew what to take but was unsure of the
length to take some medications
Y 3/12/24 months Valuable
25 Fairly confident Did not really get any information to use Y 6/9/12/18/24 months Not Valuable
26 Very confident I used it to prepare myself for the changes
to come and bought an am/pm pill sorter
to ensure I stuck to my prescription
post-op
Y 6/12/24 months Extremely valuable
27 Very confident I knew what vitamins to buy and when to
take my medication
Y 6/12 months Extremely valuable
28 Fairly confident I booked an appointment with my General
Practitioner to discuss everything after
the pharmacist appointment
Y 6 months Fairly valuable
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reported using the information sheet supplied by the pharmacist
in pre-surgical assessment as a tool to initiate discussion with
their GPs around what was needed after surgery.
Conclusions
Overall, the pharmacist role in the pre-surgical assessment was
largely perceived by all participants as positive. The findings are
limited to a small sample size of patients in one bariatric surgical
unit in the UK and may not be generalizable to other bariatric
surgical populations. Additionally, it is noted that it was more
difficult to recruit participants to take part in the surveys. It is
accepted that there is a high rate of patients who do not attend for
follow-up appointments after surgery, so they may also not wish
to take part in research; therefore, it cannot be excluded that the
participants recruited for this study may not reflect the opinions
of the total patient population within our service. Owing to the
underpinning interpretivist framework which focuses on partici-
pants’ experiences using self-reported information, many partic-
ipants were not able to give specific information about the doses
they were on and often expressed changes colloquially, e.g. ‘two
tablets instead of four’, making it difficult to provide statistically
valid information; however, the aim of the study was to under-
stand the patient-reported impact of the role of the pharmacist
and not provide a quantitative measurement of compliance.
The themes of self-care and patient empowerment can be
framed under an overall concept of gaining control, which has
been identified as important within the bariatric surgical pop-
ulation. Pre-surgically, many people feel out of control, and
afterwards regain a sense of control over their lives [13, 14].
The pharmacist is a valued resource by patients as part of
their pre-surgical assessment, but consideration should be given
to further appointments post-surgically to address medication
issues following weight loss and changes to health status, to
reinforce the importance of life-long vitamin supplementation
and management of potential side effects. Currently, the phar-
macist role is limited to pre-surgical assessment, but there is
potential for pharmacists to become more involved in the man-
agement of patients following surgery, particularly in the man-
agement of long-term chronic diseases [15]. Further research
into the role of pharmacist as an integral part of the MDT in
bariatric patient care is recommended, along with ascertaining
education and training for this specialist role in practice.
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